None of these markers differed significantly in the patients 50 years or older between BRCA1-associated cancers and control cancers, although tumours from the younger BRCA1 age group presented less frequent ER, PR, and cyclin D1 staining and more frequent Ki-67 and B-catenin staining than those from control cancers. This evidence concerns the gene BRCA1 and neoplasm.